RDNT · XBRL financial data

RadNet financial statements, every fiscal year

The same tables from 7 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (RDNT's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue	1,072	1,315	1,430	1,617	—	—
Revenue from contracts with customers	1,072	1,315	1,430	1,617	1,830	2,040
Total operating expenses	1,062	1,242	1,384	1,518	1,725	1,978
Operating income (loss)	36	83	46	99	105	62
Interest income	—	—	—	—	31	32
Interest expense	46	49	51	64	80	70
Other income (expense)	(0)	(1)	(2)	6	25	32
Income tax expense (benefit)	1	15	9	8	6	15
Net income (loss)	(15)	25	11	3	3	(19)
Earnings per share, basic USD per share	(0.29)	0.47	0.19	0.05	0.04	(0.25)
Earnings per share, diluted USD per share	(0.29)	0.46	0.17	0.05	0.04	(0.25)
Weighted average shares, basic millions of shares	51	52	56	64	73	75
Weighted average shares, diluted millions of shares	51	53	57	65	75	75

Fiscal years (RDNT's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	102	135	128	343	740	767
Accounts receivable	130	135	166	164	186	200
Prepaid and other current assets	33	49	54	48	52	52
Total current assets	270	324	367	579	1,019	1,032
Property and equipment, net	399	484	566	604	695	808
Right-of-use asset	484	584	604	596	640	690
Goodwill	473	514	678	679	711	908
Total assets	1,787	2,058	2,434	2,690	3,287	3,759
Accounts payable	70	86	103	123	96	153
Accrued liabilities	84	93	182	124	153	155
Current portion of long-term debt	40	11	12	18	25	25
Total current liabilities	398	375	467	437	480	587
Long-term debt	613	743	839	812	992	1,064
Lease liability, non-current	463	578	604	605	656	707
Total liabilities	1,528	1,712	1,942	1,877	2,153	2,403
Accumulated deficit	(118)	(93)	(83)	(80)	(77)	(95)
Total stockholders' equity	166	229	333	631	902	1,090
Total liabilities and equity	1,787	2,058	2,434	2,690	3,287	3,759
Common shares outstanding (cover page) millions of shares	52	56	58	68	74	78

Fiscal years (RDNT's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	(15)	25	11	3	3	(19)
Stock-based compensation	12	25	24	27	30	55
Depreciation and amortization	87	97	116	128	138	152
Net cash from operating activities	234	149	146	221	233	299
Net cash from investing activities	(126)	(222)	(247)	(201)	(233)	(344)
Proceeds from issuing common stock	—	0	0	246	218	0
Proceeds from long-term debt	—	—	148	0	864	99
Net cash from financing activities	(46)	105	94	196	398	72
Net change in cash	62	33	(7)	215	397	27

SIC 8071 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 8071 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Runway	Quarter
RadNet	726	623	94*	78.7M	—	Q2 FY26 10-QJun 30, 2026
Caris Life Sciences	not reported	275	not reported	286.8M	—	Q3 FY26 10-QSep 30, 2026
Guardant Health	1,053	335	(58)*	134.2M	18.2 quarters	Q2 FY26 10-QJun 30, 2026
GRAIL	56	45	(81)*	44.7M	0.7 quarters	Q2 FY26 10-QJun 30, 2026
Lumexa Imaging Holdings	70	264	33*	96.1M	—	Q2 FY26 10-QJun 30, 2026
Veracyte	300	150	46*	80.4M	—	Q2 FY26 10-QJun 30, 2026
Exact Sciences	956	878*	152*	190.9M	—	Q4 FY25 10-KDec 31, 2025
CareDx	250	139	13*	52.5M	—	Q3 FY26 10-QSep 30, 2026
Quest Diagnostics	797	3,097	611*	110.0M	—	Q3 FY26 10-QSep 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.